LOS ANGELES, Dec. 4, 2017 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced that it will be presenting at the 10th annual LD Micro Invitational on…
